Project title
探討miR-204的啟動子調控以及下游標的基因以控制腫瘤進展以及肺癌治療
Internal ID
MOST106-2314-B002-099-MY3
Principal Investigator
Start Date
August 1, 2019
End Date
July 31, 2020
Investigators
Organizations
Partner Organizations
Explore the Promoter Regulation and Downstream Targets of Mir-204 to Control Tumor Progression and Lung Cancer Treatments.
Keywords
肺癌
miR-204
EGFR TKI
EGFR mutation
stem cell
epithelial–mesenchymal transition (EMT)
肺癌
miR-204
EGFR TKI
EGFR mutation
stem cell
epithelial–mesenchymal transition (EMT)